{
    "SPADE_UN_21624": {
        "Sequence Information": {
            "Peptide Name": "Temporin-SHa [G10a]",
            "Sequence": "FLSGIVGMLAKLF",
            "Sequence Length": 13,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "B3KYH4",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/B3KYH4",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Temporin-SHa and Its Analogs as Potential Candidates for the Treatment of Helicobacter pylori.",
                    "Pubmed ID": "31614561",
                    "Reference": "Biomolecules. 2019;9:",
                    "Author": "Olleik H, Baydoun E, Perrier J, Hijazi A, Raymond J, Manzoni M, Dupuis L, Pauleau G, Goudard Y, Villeon B, Goin G, Sockeel P, Choudhary MI, Pasquale ED, Nadeem-Ul-Haque M, Ali H, Khan AI, Shaheen F, Maresca M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31614561"
                },
                {
                    "Title": "Synthesis of Second-Generation Analogs of Temporin-SHa Peptide Having Broad-Spectrum Antibacterial and Anticancer Effects",
                    "Pubmed ID": "39200058",
                    "Reference": "Antibiotics (Basel). 2024;13:758",
                    "Author": "Khan AI, Nazir S, Haque MNU, Maharjan R, Khan FA, Olleik H, Courvoisier-Dezord E, Maresca M, Shaheen F",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/39200058"
                }
            ],
            "Mass": 1395.75,
            "PI": 8.75,
            "Net Charge": 1,
            "Hydrophobicity": 1.84,
            "Frequent Amino Acids": "LFG",
            "Absent Amino Acids": "CDEHNOPQRTUWY",
            "Basic Residues": 1,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 4,
            "Positive Residues": 1,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_21624",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_14481",
                    "Similarity": 1.0,
                    "Sequence": "FLSGIVGMLAKLF"
                },
                {
                    "SPADE_ID": "SPADE_UN_21624",
                    "Similarity": 1.0,
                    "Sequence": "FLSGIVGMLAKLF"
                },
                {
                    "SPADE_ID": "SPADE_UN_26578",
                    "Similarity": 1.0,
                    "Sequence": "FLSGIVGMLKLF"
                }
            ],
            "Hemolytic Activity": "Human Lung Fibroblasts IMR-90:IC50=33.0±3.1 µM,Human bronchial epithelial cells BEAS-2B:IC50=22.6±0.7 µM",
            "Target Organism": "Helicobacter pylori ATCC 43504(MIC=1.5µM),Helicobacter pylori ATCC 43504(MIC=3.12µM),Helicobacter pylori ATCC 43504(MIC=25µM),Helicobacter pylori(MIC=6.25-12.5µM),Human gastric carcinoma NCI-N87(IC50=90.41±10.4µM),Acinetobacter baumannii DSM 30007(MIC=12.5µM),Enterobacter cloacae DSM 30054(MIC=>100µM),Escherichia coli ATCC 8739(MIC=100µM),Klebsiella pneumoniae DSM 26371(MIC=100µM),Pseudomonas aeruginosa ATCC 9027(MIC=>100µM),Bacillus subtilis ATCC 6633(MIC=3.12µM),Enterococcus faecalis DSM 2570(MIC=25µM),Enterococcus faecium DSM 20477(MIC=>100µM),Staphylococcus aureus ATCC 6538(MIC=3.12µM),Human breast adenocarcinoma MCF-7(IC50=18.3±8.0µM),Human hepatocellular carcinoma HepG2(IC50=37.2±5.0µM),Human ovarian adenocarcinoma A2780(IC50=13.4±0.7µM),Human pancreatic carcinoma Mia PaCa-2(IC50=23.1±4.3µM),Human prostate adenocarcinoma PC-3(IC50=13.1±2.4µM),Human skin melanoma MNT-1(IC50=14.0±0.8µM),Human lung carcinoma A549(IC50=12.1±0.4µM)"
        }
    }
}